Navigation Links
HRT Not That Risky For Breast Cancer

As popular thought that after HRT a woman’s risk of developing breast cancer increase manifold has been challenged. The team, based at the New South Wales Breast Cancer Institute, used the latest data to estimate a woman’s individual risk of breast cancer// up to age 79 years in relation to hormone replacement therapy. This is known as the cumulative absolute risk.

The inference obtained said that a woman’s risk of developing breast cancer while taking hormone replacement therapy may be lower than we think.

Until now, only population risk data have been available, so this analysis will help doctors to weigh the benefits and harms of treatment more accurately.

Cumulative absolute risk of breast cancer falls with increasing age in women who do not take hormone replacement therapy. The average baseline risk (from 40-79 years) is about 7.2% (1 in 14), reducing to 6.1% (1 in 16) at 50 years, and 4.4% (1 in 23) at 60 years.

Use of hormone replacement therapy increases a woman’s cumulative risk, but only slightly. For instance, use of estrogen only hormone replacement or short term (about five years) use of combined therapy starting at age 50 hardly affects the cumulative risk (no use 6.1%, estrogen only 6.3%, combined 6.7%).

Use of combined therapy for about 10 years increases the cumulative risk to 7.7%, while estrogen only formulations have a minimal effect on risk of breast cancer, even with extended use. Studies estimate one half of Australian, European, or American women taking hormone replacement therapy are taking combined preparations.

“Although we found the additional breast cancer risk with hormone replacement therapy for an individual is very small, the effect on the general incidence of breast cancer would be greater, especially in populations with high levels of use,” said Professor John Boyages, the Director of the Institute

“The reasons for taking hormone replacement therapy vary a nd decisions about its use must be made at an individual level. Our analysis provides women and clinicians with better information to make these choices,” they conclude.

Source:BMJ
'"/>




Related medicine news :

1. Herbal Remedy Risky for Cancer Patients
2. Risky Drugs To Be Avoided In The Elderly
3. Coffee In Pregnancy May Be Risky: Study
4. Distinct Brain Sections Are Activated While Making Risky Decisions
5. Americans Avoiding Risky Foods
6. Heavy Dosage Of Vitamin Supplements May Be Risky For Pregnant Women
7. Males Show More Risky Behaviour with Alcohol
8. Risky Behavior In Teenagers Leads To Depression
9. Insight Into The Risky Health Decisions On Bird Flu
10. Brachytherapy For Breast Cancer Can Be Risky
11. WHO Warns, Female Mutilation Is Risky And Cruel
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2017)... ... July 26, 2017 , ... An inventor from Salisbury, N.C., ... haven’t yet seen an effective and dignified way to keep leeches in place during ... CUP." , This invention provides an effective way to keep a leech in place ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs ... freeze drying samples and a lengthy freeze dry cycle are a few common challenges ... drying techniques, as well as new accessories and advancements in laboratory freeze dryers that ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... the cloud ; today announced the availability of its latest data protection solution ... use control console for Data Discovery, Classification, Encryption and Digital Rights Management; GTB ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and ... from April 1, 2017 to June 30, 2017. Iso International LLC recorded unaudited ...
(Date:7/25/2017)... St. Louis, MO (PRWEB) , ... July 25, 2017 , ... ... (HDIS) in St. Louis, Missouri. The company has achieved record-breaking sales for ... multiple departments over the next 12 months. , The upcoming year offers excitement and ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/26/2017)... NEW YORK , July 26, 2017 ... Annual Prix Galien USA Award ... honors, the Prix Galien Award recognizes outstanding biomedical and technology ... To qualify, each candidate must be ... the last five years and demonstrate tremendous potential to impact ...
(Date:7/24/2017)... 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... second quarter 2017 operating results on Monday, August 7, ... follow at 5:00 p.m. ET. ... a live broadcast of the conference call by dialing ... code 51641230 approximately 15 minutes prior to the call. ...
Breaking Medicine Technology: